AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/111
WHY DO WE NOT HAVE AN HIV VACCINE AND HOW CAN WE MAKE ONE
Authors: BURTON DR MOORE JP
Citation: Dr. Burton et Jp. Moore, WHY DO WE NOT HAVE AN HIV VACCINE AND HOW CAN WE MAKE ONE, Nature medicine, 4(5), 1998, pp. 495-498
A CHEMOKINE RECEPTOR CCR2 ALLELE DELAYS HIV-1 DISEASE PROGRESSION ANDIS ASSOCIATED WITH A CCR5 PROMOTER MUTATION
Authors: KOSTRIKIS LG HUANG YX MOORE JP WOLINSKY SM ZHANG LQ GUO Y DEUTSCH L PHAIR J NEUMANN AU HO DD
Citation: Lg. Kostrikis et al., A CHEMOKINE RECEPTOR CCR2 ALLELE DELAYS HIV-1 DISEASE PROGRESSION ANDIS ASSOCIATED WITH A CCR5 PROMOTER MUTATION, Nature medicine, 4(3), 1998, pp. 350-353
AMD310, A SMALL-MOLECULE INHIBITOR OF HIV-1 ENTRY VIA THE CXCR4 CORECEPTOR
Authors: DONZELLA GA SCHOLS D LIN SW ESTE JA NAGASHIMA KA MADDON PJ ALLAWAY GP SAKMAR TP HENSON G DECLERCQ E MOORE JP
Citation: Ga. Donzella et al., AMD310, A SMALL-MOLECULE INHIBITOR OF HIV-1 ENTRY VIA THE CXCR4 CORECEPTOR, Nature medicine, 4(1), 1998, pp. 72-77
HOT PAPERS - HIV AND AIDS - CD4-DEPENDENT, ANTIBODY-SENSITIVE INTERACTIONS BETWEEN HIV-1 AND ITS CORECEPTOR CCR-5 BY TRKOLA,A., DRAGIC,T., ARTHOS,J., BINLEY,J.M., OLSON,W.C., ALLAWAY,G.P., CHENGMAYER,C., ROBINSON,J., MADDON,P.J., MOORE,J.P. - COMMENTS
Authors: MOORE JP TRKOLA A
Citation: Jp. Moore et A. Trkola, HOT PAPERS - HIV AND AIDS - CD4-DEPENDENT, ANTIBODY-SENSITIVE INTERACTIONS BETWEEN HIV-1 AND ITS CORECEPTOR CCR-5 BY TRKOLA,A., DRAGIC,T., ARTHOS,J., BINLEY,J.M., OLSON,W.C., ALLAWAY,G.P., CHENGMAYER,C., ROBINSON,J., MADDON,P.J., MOORE,J.P. - COMMENTS, The Scientist, 12(16), 1998, pp. 11-11
INTERACTIONS OF POLYCLONAL AND MONOCLONAL ANTI-GLYCOPROTEIN-120 ANTIBODIES WITH OLIGOMERIC GLYCOPROTEIN-120 GLYCOPROTEIN-41 COMPLEXES OF A PRIMARY HIV TYPE-1 ISOLATE - RELATIONSHIP TO NEUTRALIZATION
Authors: FOUTS TR TRKOLA A FUNG MS MOORE JP
Citation: Tr. Fouts et al., INTERACTIONS OF POLYCLONAL AND MONOCLONAL ANTI-GLYCOPROTEIN-120 ANTIBODIES WITH OLIGOMERIC GLYCOPROTEIN-120 GLYCOPROTEIN-41 COMPLEXES OF A PRIMARY HIV TYPE-1 ISOLATE - RELATIONSHIP TO NEUTRALIZATION, AIDS research and human retroviruses, 14(7), 1998, pp. 591-597
EXPRESSION PATTERNS OF THE HIV TYPE-1 CORECEPTORS CCR5 AND CXCR4 ON CD4(-CELLS AND MONOCYTES FROM CORD AND ADULT-BLOOD() T)
Authors: MO HM MONARD S POLLACK H IP J ROCHFORD G WU LJ HOXIE J BORKOWSKY W HO DD MOORE JP
Citation: Hm. Mo et al., EXPRESSION PATTERNS OF THE HIV TYPE-1 CORECEPTORS CCR5 AND CXCR4 ON CD4(-CELLS AND MONOCYTES FROM CORD AND ADULT-BLOOD() T), AIDS research and human retroviruses, 14(7), 1998, pp. 607-617
ANALYSIS OF THE INTERACTION OF ANTIBODIES WITH A CONSERVED, ENZYMATICALLY DEGLYCOSYLATED CORE OF THE HIV TYPE-1 ENVELOPE GLYCOPROTEIN-120
Authors: BINLEY JM WYATT R DESJARDINS E KWONG PD HENDRICKSON W MOORE JP SODROSKI J
Citation: Jm. Binley et al., ANALYSIS OF THE INTERACTION OF ANTIBODIES WITH A CONSERVED, ENZYMATICALLY DEGLYCOSYLATED CORE OF THE HIV TYPE-1 ENVELOPE GLYCOPROTEIN-120, AIDS research and human retroviruses, 14(3), 1998, pp. 191-198
IMPACT OF THE NEW-ZEALAND FLATWORM (ARTIOPOSTHIA-TRIANGULATA) ON SOIL-STRUCTURE AND HYDROLOGY IN THE UK
Authors: HARIA AH MCGRATH SP MOORE JP BELL JP BLACKSHAW RP
Citation: Ah. Haria et al., IMPACT OF THE NEW-ZEALAND FLATWORM (ARTIOPOSTHIA-TRIANGULATA) ON SOIL-STRUCTURE AND HYDROLOGY IN THE UK, Science of the total environment, 215(3), 1998, pp. 259-265
COMPARISONS OF POPULATIONS OF AUSTRALOPLANA-SANGUINEA-ALBA, THE AUSTRALIAN FLATWORM, IN THE BRITISH-ISLES
Authors: DYNES C FLEMING CC MOORE JP
Citation: C. Dynes et al., COMPARISONS OF POPULATIONS OF AUSTRALOPLANA-SANGUINEA-ALBA, THE AUSTRALIAN FLATWORM, IN THE BRITISH-ISLES, Pedobiologia, 42(5-6), 1998, pp. 541-541
STATUS AND PUBLIC PERCEPTION OF THE NEW-ZEALAND FLATWORM, ARTIOPOSTHIA-TRIANGULATA (DENDY), IN NORTHERN-IRELAND
Authors: MOORE JP DYNES C MURCHIE AK
Citation: Jp. Moore et al., STATUS AND PUBLIC PERCEPTION OF THE NEW-ZEALAND FLATWORM, ARTIOPOSTHIA-TRIANGULATA (DENDY), IN NORTHERN-IRELAND, Pedobiologia, 42(5-6), 1998, pp. 563-571
HOT-WATER TREATMENT TO PREVENT TRANSFERENCE OF THE NEW-ZEALAND FLATWORM, ARTIOPOSTHIA-TRIANGULATA
Authors: MURCHIE AK MOORE JP
Citation: Ak. Murchie et Jp. Moore, HOT-WATER TREATMENT TO PREVENT TRANSFERENCE OF THE NEW-ZEALAND FLATWORM, ARTIOPOSTHIA-TRIANGULATA, Pedobiologia, 42(5-6), 1998, pp. 572-572
HIV - ENVELOPES LETTERS BOXED INTO SHAPE
Authors: MOORE JP BINLEY J
Citation: Jp. Moore et J. Binley, HIV - ENVELOPES LETTERS BOXED INTO SHAPE, Nature, 393(6686), 1998, pp. 630-631
A NEW CLASSIFICATION FOR HIV-1
Authors: BERGER EA DOMS RW FENYO EM KORBER BTM LITTMAN DR MOORE JP SATTENTAU QJ SCHUITEMAKER H SODROSKI J WEISS RA
Citation: Ea. Berger et al., A NEW CLASSIFICATION FOR HIV-1, Nature, 391(6664), 1998, pp. 240-240
TEMPORAL ANALYSES OF VIRUS-REPLICATION, IMMUNE-RESPONSES, AND EFFICACY IN RHESUS MACAQUES IMMUNIZED WITH A LIVE, ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS-VACCINE
Authors: CONNOR RI MONTEFIORI DC BINLEY JM MOORE JP BONHOEFFER S GETTIE A FENAMORE EA SHERIDAN KE HO DD DAILEY PJ MARX PA
Citation: Ri. Connor et al., TEMPORAL ANALYSES OF VIRUS-REPLICATION, IMMUNE-RESPONSES, AND EFFICACY IN RHESUS MACAQUES IMMUNIZED WITH A LIVE, ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS-VACCINE, Journal of virology, 72(9), 1998, pp. 7501-7509
ALANINE SUBSTITUTIONS OF POLAR AND NONPOLAR RESIDUES IN THE AMINO-TERMINAL DOMAIN OF CCR5 DIFFERENTLY IMPAIR ENTRY OF MACROPHAGE AND DUALTROPIC ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: RABUT GEE KONNER JA KAJUMO F MOORE JP DRAGIC T
Citation: Gee. Rabut et al., ALANINE SUBSTITUTIONS OF POLAR AND NONPOLAR RESIDUES IN THE AMINO-TERMINAL DOMAIN OF CCR5 DIFFERENTLY IMPAIR ENTRY OF MACROPHAGE AND DUALTROPIC ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 72(4), 1998, pp. 3464-3468
PERSISTENT ANTIBODY-RESPONSES BUT DECLINING CYTOTOXIC T-LYMPHOCYTE RESPONSES TO MULTIPLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGENS IN A LONG-TERM NONPROGRESSING INDIVIDUAL WITH A DEFECTIVE P17 PROVIRAL SEQUENCE AND NO DETECTABLE VIRAL-RNA EXPRESSION
Authors: BINLEY JM JIN X HUANG YX ZHANG LQ CAO YZ HO DD MOORE JP
Citation: Jm. Binley et al., PERSISTENT ANTIBODY-RESPONSES BUT DECLINING CYTOTOXIC T-LYMPHOCYTE RESPONSES TO MULTIPLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGENS IN A LONG-TERM NONPROGRESSING INDIVIDUAL WITH A DEFECTIVE P17 PROVIRAL SEQUENCE AND NO DETECTABLE VIRAL-RNA EXPRESSION, Journal of virology, 72(4), 1998, pp. 3472-3474
NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES TO ANTIBODIES AND CD4-BASED REAGENTS IS INDEPENDENT OF CORECEPTOR USAGE
Authors: TRKOLA A KETAS T KEWALRAMANI VN ENDORF F BINLEY JM KATINGER H ROBINSON J LITTMAN DR MOORE JP
Citation: A. Trkola et al., NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES TO ANTIBODIES AND CD4-BASED REAGENTS IS INDEPENDENT OF CORECEPTOR USAGE, Journal of virology, 72(3), 1998, pp. 1876-1885
EVIDENCE THAT ANTIBODY-MEDIATED NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SERA FROM INFECTED INDIVIDUALS IS INDEPENDENT OF CORECEPTOR USAGE
Authors: MONTEFIORI DC COLLMAN RG FOUTS TR ZHOU JY BILSKA M HOXIE JA MOORE JP BOLOGNESI DP
Citation: Dc. Montefiori et al., EVIDENCE THAT ANTIBODY-MEDIATED NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SERA FROM INFECTED INDIVIDUALS IS INDEPENDENT OF CORECEPTOR USAGE, Journal of virology, 72(3), 1998, pp. 1886-1893
IMMUNOLOGICAL AND VIROLOGICAL ANALYSES OF PERSONS INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHILE PARTICIPATING IN TRIALS OF RECOMBINANT GP120 SUBUNIT VACCINES
Authors: CONNOR RI KORBER BTM GRAHAM BS HAHN BH HO DD WALKER BD NEUMANN AU VERMUND SH MESTECKY J JACKSON S FENAMORE E CAO Y GAO F KALAMS S KUNSTMAN KJ MCDONALD D MCWILLIAMS N TRKOLA A MOORE JP WOLINSKY SM
Citation: Ri. Connor et al., IMMUNOLOGICAL AND VIROLOGICAL ANALYSES OF PERSONS INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHILE PARTICIPATING IN TRIALS OF RECOMBINANT GP120 SUBUNIT VACCINES, Journal of virology, 72(2), 1998, pp. 1552-1576
ANTIBODY NEUTRALIZATION-RESISTANT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: PARREN PWHI WANG M TRKOLA A BINLEY JM PURTSCHER M KATINGER H MOORE JP BURTON DR
Citation: Pwhi. Parren et al., ANTIBODY NEUTRALIZATION-RESISTANT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology (Print), 72(12), 1998, pp. 10270-10274
USE OF CORECEPTORS OTHER THAN CCR5 BY NON-SYNCYTIUM-INDUCING ADULT AND PEDIATRIC ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS RARE IN-VITRO
Authors: ZHANG YJ DRAGIC T CAO YZ KOSTRIKIS L KWON DS LITTMAN DR KEWALRAMANI VN MOORE JP
Citation: Yj. Zhang et al., USE OF CORECEPTORS OTHER THAN CCR5 BY NON-SYNCYTIUM-INDUCING ADULT AND PEDIATRIC ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS RARE IN-VITRO, Journal of virology (Print), 72(11), 1998, pp. 9337-9344
AMINO-TERMINAL SUBSTITUTIONS IN THE CCR5 CORECEPTOR IMPAIR GP120 BINDING AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENTRY
Authors: DRAGIC T TRKOLA A LIN SW NAGASHIMA KA KAJUMO F ZHAO L OLSON WC WU LJ MACKAY CR ALLAWAY GP SAKMAR TP MOORE JP MADDON PJ
Citation: T. Dragic et al., AMINO-TERMINAL SUBSTITUTIONS IN THE CCR5 CORECEPTOR IMPAIR GP120 BINDING AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENTRY, Journal of virology, 72(1), 1998, pp. 279-285
GENETIC SUBTYPE-INDEPENDENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY CC AND CXC CHEMOKINES
Authors: TRKOLA A PAXTON WA MONARD SP HOXIE JA SIANI MA THOMPSON DA WU LJ MACKAY CR HORUK R MOORE JP
Citation: A. Trkola et al., GENETIC SUBTYPE-INDEPENDENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY CC AND CXC CHEMOKINES, Journal of virology, 72(1), 1998, pp. 396-404
CLINICAL-TRIALS OF HIVIG
Authors: MOORE JP
Citation: Jp. Moore, CLINICAL-TRIALS OF HIVIG, The Journal of infectious diseases, 178(2), 1998, pp. 597-598
HIV-1 ANTIGEN-SPECIFIC AND ANTIGEN-NONSPECIFIC B-CELL RESPONSES ARE SENSITIVE TO COMBINATION ANTIRETROVIRAL THERAPY
Authors: MORRIS L BINLEY JM CLAS BA BONHOEFFER S ASTILL TP KOST R HURLEY A CAO YZ MARKOWITZ M HO DD MOORE JP
Citation: L. Morris et al., HIV-1 ANTIGEN-SPECIFIC AND ANTIGEN-NONSPECIFIC B-CELL RESPONSES ARE SENSITIVE TO COMBINATION ANTIRETROVIRAL THERAPY, The Journal of experimental medicine, 188(2), 1998, pp. 233-245
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>